[Cutanea tarda porphyria in 2 patients with kidney transplantation].
Two patients who developed porphyria cutanea tarda, six and eight years after a successful renal transplantation are reported. There was no history, in either of them, of alcohol abuse, blood transfusion, iron or estrogen therapy and any hemodialysis in the last years. There is no evidence to support that a renal allograft is capable to develop porphyria cutanea tarda. Nevertheless, it would be interesting to consider its possible influence, due to the longer survival of these patients.
Melero
M J
MJ
Departamento de Medicina, Hospital de Clínicas José de San Martín, Facultad de Medicina, Universidad de Buenos Aires, Argentina.
Mattar
D E
DE
Stengel
F M
FM
Politi
A J
AJ
Idiarte
L B
LB
Bacque
M C
MC
D000328:Adult; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D016030:Kidney Transplantation; D008297:Male; D017119:Porphyria Cutanea Tarda / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006435:Renal Dialysis / Q000009:adverse effects; D013997:Time Factors
D006886:Hydroxychloroquine
Porfiria cutánea tarda en dos pacientes con trasplante renal.